Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Revenue 2010-2023 | MKGAF

Merck annual/quarterly revenue history and growth rate from 2010 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Merck revenue for the quarter ending December 31, 2023 was $5.628B, a 3.26% decline year-over-year.
  • Merck revenue for the twelve months ending December 31, 2023 was $22.721B, a 3% decline year-over-year.
  • Merck annual revenue for 2023 was $22.721B, a 3% decline from 2022.
  • Merck annual revenue for 2022 was $23.424B, a 0.57% increase from 2021.
  • Merck annual revenue for 2021 was $23.292B, a 16.29% increase from 2020.
  
Merck Annual Revenue
(Millions of US $)
2023 $22,721
2022 $23,424
2021 $23,292
2020 $20,029
2019 $18,090
2018 $17,521
2017 $17,324
2016 $16,626
2015 $14,254
2014 $15,288
2013 $14,738
2012 $14,369
2011 $13,799
2010 $12,338
2009 $10,807
Merck Quarterly Revenue
(Millions of US $)
2023-12-31 $5,628
2023-09-30 $5,630
2023-06-30 $5,781
2023-03-31 $5,682
2022-12-31 $5,817
2022-09-30 $5,848
2022-06-30 $5,925
2022-03-31 $5,833
2021-12-31 $5,977
2021-09-30 $5,864
2021-06-30 $5,868
2021-03-31 $5,583
2020-12-31 $5,474
2020-09-30 $5,199
2020-06-30 $4,535
2020-03-31 $4,821
2019-12-31 $4,864
2019-09-30 $4,508
2019-06-30 $4,464
2019-03-31 $4,255
2018-12-31 $4,196
2018-09-30 $4,359
2018-06-30 $4,429
2018-03-31 $4,537
2017-12-31 $4,549
2017-09-30 $4,380
2017-06-30 $4,280
2017-03-31 $4,115
2016-12-31 $4,128
2016-09-30 $4,156
2016-06-30 $4,298
2016-03-31 $4,043
2015-12-31 $3,795
2015-09-30 $3,489
2015-06-30 $3,560
2015-03-31 $3,464
2014-12-31 $3,398
2014-09-30 $3,896
2014-06-30 $3,827
2014-03-31 $3,654
2013-12-31 $3,729
2013-09-30 $3,645
2013-06-30 $3,769
2013-03-31 $3,581
2012-12-31 $3,646
2012-09-30 $3,555
2012-06-30 $3,520
2012-03-31 $3,274
2011-12-31 $3,311
2011-09-30 $3,585
2011-06-30 $3,677
2011-03-31 $3,505
2010-12-31 $3,707
2010-09-30 $3,145
2010-06-30 $2,695
2010-03-31 $2,791
2009-12-31 $2,983
2009-09-30 $2,778
2009-06-30 $2,590
2009-03-31 $2,456
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $22.694B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.067B 32.15
Chugai Pharmaceutical (CHGCY) Japan $51.455B 23.00
Takeda Pharmaceutical (TAK) Japan $42.377B 8.58
Astellas Pharma (ALPMY) Japan $17.735B 28.00
Sandoz Group AG (SDZNY) Switzerland $15.417B 0.00
Neurocrine Biosciences (NBIX) United States $14.290B 39.12
Shionogi (SGIOY) Japan $13.866B 12.05
United Therapeutics (UTHR) United States $12.095B 12.89
Catalent (CTLT) United States $10.064B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.683B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.918B 7.61
Revolution Medicines (RVMD) United States $6.499B 0.00
Ionis Pharmaceuticals (IONS) United States $5.723B 0.00
Orion OYJ (ORINY) Finland $5.645B 23.81
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.512B 0.00
Alpine Immune Sciences (ALPN) United States $4.457B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.982B 0.00
Summit Therapeutics (SMMT) United States $3.152B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.110B 0.00
Corcept Therapeutics (CORT) United States $2.897B 26.25
PTC Therapeutics (PTCT) United States $2.582B 0.00
Dyne Therapeutics (DYN) United States $2.567B 0.00
Indivior (INDV) United States $2.416B 11.45
Recursion Pharmaceuticals (RXRX) United States $2.349B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.109B 12.05
Evotec AG (EVO) Germany $2.009B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.968B 19.15
Fusion Pharmaceuticals (FUSN) Canada $1.832B 0.00
Ardelyx (ARDX) United States $1.827B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.768B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.592B 27.86
Soleno Therapeutics (SLNO) United States $1.511B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.457B 0.00
Pacira BioSciences (PCRX) United States $1.400B 13.31
4D Molecular Therapeutics (FDMT) United States $1.323B 0.00
Xencor (XNCR) United States $1.313B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.313B 0.00
Enliven Therapeutics (ELVN) United States $1.129B 0.00
Collegium Pharmaceutical (COLL) United States $1.112B 6.65
Cronos Group (CRON) Canada $1.108B 0.00
Cassava Sciences (SAVA) United States $1.104B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.027B 16.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.994B 0.00
Ocular Therapeutix (OCUL) United States $0.974B 0.00
USANA Health Sciences (USNA) United States $0.913B 14.93
Relay Therapeutics (RLAY) United States $0.902B 0.00
ProKidney (PROK) United States $0.899B 0.00
ARS Pharmaceuticals (SPRY) United States $0.860B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.758B 0.00
Sage Therapeutics (SAGE) United States $0.705B 0.00
Silence Therapeutics (SLN) United Kingdom $0.668B 0.00
Savara (SVRA) United States $0.667B 0.00
Lyell Immunopharma (LYEL) United States $0.665B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.659B 0.00
Altimmune (ALT) United States $0.629B 0.00
Exscientia (EXAI) United Kingdom $0.620B 0.00
Harrow (HROW) United States $0.563B 0.00
Siga Technologies (SIGA) United States $0.555B 7.09
OmniAb (OABI) United States $0.532B 0.00
Verve Therapeutics (VERV) United States $0.523B 0.00
KalVista Pharmaceuticals (KALV) United States $0.507B 0.00
Bioventus (BVS) United States $0.503B 19.24
Larimar Therapeutics (LRMR) United States $0.502B 0.00
Korro Bio (KRRO) United States $0.489B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.478B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.472B 0.00
Lexeo Therapeutics (LXEO) United States $0.460B 0.00
Heron Therapeutics (HRTX) United States $0.452B 0.00
Esperion Therapeutics (ESPR) United States $0.436B 0.00
Organogenesis (ORGO) United States $0.394B 74.25
Tourmaline Bio (TRML) United States $0.391B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.386B 0.00
Nanobiotix S.A (NBTX) France $0.345B 0.00
Fractyl Health (GUTS) United States $0.342B 0.00
Nektar Therapeutics (NKTR) United States $0.336B 0.00
Black Diamond Therapeutics (BDTX) United States $0.306B 0.00
Nature's Sunshine Products (NATR) United States $0.295B 18.76
Xeris Biopharma Holdings (XERS) United States $0.294B 0.00
Aquestive Therapeutics (AQST) United States $0.293B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.283B 0.00
ESSA Pharma (EPIX) Canada $0.275B 0.00
Metagenomi (MGX) United States $0.255B 0.00
Pyxis Oncology (PYXS) United States $0.248B 0.00
Aldeyra Therapeutics (ALDX) United States $0.248B 0.00
Akebia Therapeutics (AKBA) United States $0.247B 0.00
Foghorn Therapeutics (FHTX) United States $0.225B 0.00
Eliem Therapeutics (ELYM) United States $0.222B 0.00
Conduit Pharmaceuticals (CDT) United States $0.219B 0.00
Avita Medical (RCEL) United States $0.212B 0.00
Profound Medical (PROF) Canada $0.209B 0.00
Zevra Therapeutics (ZVRA) United States $0.202B 0.00
Century Therapeutics (IPSC) United States $0.200B 0.00
Acrivon Therapeutics (ACRV) United States $0.196B 0.00
Adherex Technologies (FENC) United States $0.191B 232.67
Galectin Therapeutics (GALT) United States $0.189B 0.00
Incannex Healthcare (IXHL) Australia $0.184B 0.00
Telomir Pharmaceuticals (TELO) United States $0.184B 0.00
Achieve Life Sciences (ACHV) Canada $0.179B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.170B 0.00
MediWound (MDWD) Israel $0.169B 0.00
Prelude Therapeutics (PRLD) United States $0.168B 0.00
VAXART, INC (VXRT) United States $0.167B 0.00
CytoDyn (CYDY) United States $0.164B 0.00
Cardiol Therapeutics (CRDL) Canada $0.158B 0.00
Elite Pharmaceuticals (ELTP) United States $0.149B 13.99
OptiNose (OPTN) United States $0.134B 0.00
Karyopharm Therapeutics (KPTI) United States $0.133B 0.00
Regulus Therapeutics (RGLS) United States $0.132B 0.00
Context Therapeutics (CNTX) United States $0.127B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.124B 8.27
FibroGen (FGEN) United States $0.118B 0.00
Citius Pharmaceuticals (CTXR) United States $0.113B 0.00
PMV Pharmaceuticals (PMVP) United States $0.111B 0.00
Relmada Therapeutics (RLMD) United States $0.105B 0.00
Vivani Medical (VANI) United States $0.105B 0.00
ProPhase Labs (PRPH) United States $0.098B 0.00
Assertio Holdings (ASRT) United States $0.096B 4.39
AlloVir (ALVR) United States $0.086B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
SCYNEXIS (SCYX) United States $0.085B 1.20
Aclaris Therapeutics (ACRS) United States $0.084B 0.00
Protara Therapeutics (TARA) United States $0.076B 0.00
Tempest Therapeutics (TPST) United States $0.075B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.073B 0.00
Journey Medical (DERM) United States $0.072B 0.00
Jaguar Animal Health (JAGX) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.065B 0.00
Mural Oncology (MURA) Ireland $0.065B 0.00
Carisma Therapeutics (CARM) United States $0.058B 0.00
Inotiv (NOTV) United States $0.058B 0.00
Nutriband (NTRB) United States $0.055B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.053B 0.00
BioLineRx (BLRX) Israel $0.049B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.048B 0.00
Gain Therapeutics (GANX) United States $0.047B 0.00
ElectroCore (ECOR) United States $0.044B 0.00
CASI Pharmaceuticals (CASI) China $0.044B 0.00
Natural Alternatives (NAII) United States $0.042B 0.00
Unicycive Therapeutics (UNCY) United States $0.041B 0.00
VYNE Therapeutics (VYNE) United States $0.040B 0.00
Rafael Holdings (RFL) United States $0.038B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
Viracta Therapeutics (VIRX) United States $0.033B 0.00
Surrozen (SRZN) United States $0.032B 0.00
JanOne (JAN) United States $0.031B 0.00
Lipocine (LPCN) United States $0.030B 0.00
DURECT (DRRX) United States $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Oncternal Therapeutics (ONCT) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
Aptorum Group (APM) United Kingdom $0.024B 0.00
TherapeuticsMD (TXMD) United States $0.024B 0.00
PolyPid (PYPD) Israel $0.023B 0.00
Lyra Therapeutics (LYRA) United States $0.022B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.021B 0.79
Talphera (TLPH) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Indaptus Therapeutics (INDP) United States $0.019B 0.00
Alaunos Therapeutics (TCRT) United States $0.019B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
CERo Therapeutics Holdings (CERO) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.017B 0.00
Mannatech (MTEX) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.015B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.014B 0.00
Inhibikase Therapeutics (IKT) United States $0.013B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
Avalo Therapeutics (AVTX) United States $0.011B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.010B 0.00
Molecular Templates (MTEM) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
TransCode Therapeutics (RNAZ) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Clever Leaves Holdings (CLVR) Canada $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Avenue Therapeutics (ATXI) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.98
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 34.78